Trimb expands in skin care
This article was originally published in OTC Bulletin
Executive Summary
Sweden’s Trimb Healthcare is poised to expand its consumer healthcare offering by acquiring a portfolio of skin-care brands from CCS Healthcare Nordic for an undisclosed sum. The transaction is expected to close in January 2019.
You may also be interested in...
Sweden's Trimb Grows European Offering With BioClin Acquisition
Trimb has snapped up Netherlands-based BioClin and gained a portfolio of consumer health brands based on a patented ingredient for the treatment and prevention of microbial complaints.
Alvotech Highlights Lack Of Simponi Rivals As It Delivers Golimumab Results
Alvotech has just become the first company to announce positive topline results from a confirmatory clinical study for a proposed golimumab rival to Simponi and Simponi Aria – and moreover, the firm sees limited competition from other biosimilars on the horizon.
Xbrane Assembles The Troops As FDA Says No To Lucentis Biosimilar
Xbrane Biopharma was riding the crest of a wave with the EU launch of its biosimilar to Lucentis, following years of toil and investment. However, plans to roll out the product in the US will have to be pushed back – likely – into the middle of 2025, following a US FDA complete response letter.